Nexafed

Nexafed is a formulation of pseudoephedrine developed by Acura Pharmaceuticals used to deter the use of the pseudoephedrine contained in the product for illicit methamphetamine synthesis.[1] Nexafed uses a polymer matrix that forms a thick gel when hydrated, preventing the extraction of pseudoephedrine.[2] Nexafed is the only meth-resistant formulation of pseudoephedrine that shows therapeutic equivalence to Sudafed.[3]

It is sold at various pharmacies in the US, including Fruth Pharmacy[4][5] and Kroger, particularly in communities where illicit methamphetamine production is an issue.

References
  1. "In fight against crystal meth, a focus on chemistry". cbsnews.com. Retrieved 18 July 2016.
  2. Ricker, Nok-Noi (2016-07-02). "Pharmacies in northern Maine halt sales of certain decongestants to thwart meth labs". Bangor Daily News. Retrieved 2021-11-07.
  3. Brzeczko, Albert W.; Leech, Ronald; Stark, Jeffrey G. (2013). "The advent of a new pseudoephedrine product to combat methamphetamine abuse". The American Journal of Drug and Alcohol Abuse. 39 (5): 284–290. doi:10.3109/00952990.2013.821476. ISSN 0095-2990. PMC 3793278. PMID 23968171.
  4. "Fruth Pharmacy recognized for fighting meth production". drugstorenews.com. Retrieved 18 July 2016.
  5. Anna Baxter, The Associated Press. "Fruth Pharmacy to Stop Selling Certain Medications to Fight Meth Abuse". wsaz.com. Retrieved 18 July 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.